Results provide evidencethat breast cancer derived ASCs are differentfrom normal ASCs in the expression of inhibitorymolecules such as IDO and HLA-G5 and this typeof stem cell can exert inhibitory effects on theexpression of activating NK receptors. This evidence concerns the gene IDO1 and breast carcinoma.